Nuveen
CTSO icon

Nuveen’s Cytosorbents Corp CTSO Stock Holding History

Nuveen’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,757
Closed -$420K – 3296
2022
Q1 		$420K Buy
6,757
+57
+0.9% +$4.08K ﹤0.01% 3062
2021
Q4 		$594K Sell
6,700
-689
-9% -$77.3K ﹤0.01% 3027
2021
Q3 		$1.29M Sell
7,389
-214
-3% -$34.8K ﹤0.01% 2881
2021
Q2 		$1.15M Sell
7,603
-477
-6% -$80.4K ﹤0.01% 2957
2021
Q1 		$1.4M Buy
8,080
+46
+0.6% +$8.77K ﹤0.01% 2771
2020
Q4 		$1.28M Buy
8,034
+589
+8% +$98.6K ﹤0.01% 2714
2020
Q3 		$1.19M Buy
7,445
+380
+5% +$68.6K ﹤0.01% 2611
2020
Q2 		$1.4M Buy
7,065
+1,030
+17% +$189K ﹤0.01% 2479
2020
Q1 		$933K Buy
6,035
+515
+9% +$52K ﹤0.01% 2541
2019
Q4 		$425K Hold
5,520
– – ﹤0.01% 2943
2019
Q3 		$555K Sell
5,520
-307
-5% -$35.7K ﹤0.01% 2908
2019
Q2 		$770K Buy
+5,827
New +$801K ﹤0.01% 2848

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen's CTSO Position: Q2 2022 in Review

Nuveen sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 6,757 shares — an estimated $420K sold.

Nuveen first reported a position in CTSO in Q2 2019 and held it in 12 quarters. The position peaked at $1.4M in Q1 2021. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Nuveen reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 6,757 Cytosorbents Corp shares in Q2 2022, an estimated $420K.
  • Nuveen first reported a position in Cytosorbents Corp in Q2 2019 and held it in 12 quarters.
  • Nuveen's Cytosorbents Corp position peaked at $1.4M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.